BREAST-CANCER RISK IN RELATION TO TYPE OF ESTROGEN CONTAINED IN ORAL-CONTRACEPTIVES

被引：18

作者：

SCHLESSELMAN, JJ ^{[1
]}

STADEL, BV ^{[1
]}

MURRAY, P ^{[1
]}

LAI, SH ^{[1
]}

机构：

[1] NIHHD,CTR POPULAT RES,CONTRACEPT EVALUAT BRANCH,BETHESDA,MD 20892

来源：

CONTRACEPTION | 1987年 / 36卷 / 06期

关键词：

D O I：

10.1016/0010-7824(87)90033-3

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：595 / 613

页数：19

共 25 条

[1]

ANDERSON TJ, 1984, LANCET, V1, P99

[2]

[Anonymous], 1986, NEW ENGL J MED, V315, P405

[3]

ARMSTRONG BK, 1986, LANCET, V1, P552

[4] WHICH PILL [J].

DRIFE, J .

BRITISH MEDICAL JOURNAL, 1983, 287 (6403) :1397-1399

[5]

GILLMER MDG, 1983, LANCET, V2, P1145

[6] BREAST-CANCER IN RELATION TO PATTERNS OF ORAL-CONTRACEPTIVE USE [J].

HARRIS, NV ;

WEISS, NS ;

FRANCIS, AM ;

POLISSAR, L .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 1982, 116 (04) :643-651

[7]

Kelsey JL, 1983, BREAST GYNECOLOGIC C

[8]

MCPHERSON K, 1986, LANCET, V1, P685

[9] THE PILL AND BREAST-CANCER - WHY THE UNCERTAINTY [J].

MCPHERSON, K ;

DRIFE, JO .

BRITISH MEDICAL JOURNAL, 1986, 293 (6549) :709-710

[10]

MCPHERSON K, 1983, LANCET, V2, P1414

← 1 2 3 →